Abstract
Inhibition of AP-2-associated protein kinase 1 (AAK1) has been shown to be a promising avenue for the development of broad-spectrum antiviral agents. On a previously described AAK1 inhibitor based on a pyrrolo[2,3-b]pyridine scaffold, the concept of isosterism was applied, by replacing a carboxamide linker by various five-membered heterocycles. It led to the discovery of a novel series of AAK1 inhibitors with IC50 values in the low nM range, that also displayed antiviral activity against the dengue virus and Venezuelan equine encephalitis virus.
Keywords:
7-Azaindole; Adaptor-associated kinase 1; Antivirals; pyrrolo[2-3-b]pyridine.
Copyright © 2024 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Animals
-
Antiviral Agents* / chemical synthesis
-
Antiviral Agents* / chemistry
-
Antiviral Agents* / pharmacology
-
Dengue Virus / drug effects
-
Dengue Virus / enzymology
-
Dose-Response Relationship, Drug
-
Humans
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Protein Kinase Inhibitors* / chemical synthesis
-
Protein Kinase Inhibitors* / chemistry
-
Protein Kinase Inhibitors* / pharmacology
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / metabolism
-
Pyridines* / chemical synthesis
-
Pyridines* / chemistry
-
Pyridines* / pharmacology
-
Pyrroles* / chemical synthesis
-
Pyrroles* / chemistry
-
Pyrroles* / pharmacology
-
Structure-Activity Relationship
Substances
-
Antiviral Agents
-
Pyridines
-
Protein Kinase Inhibitors
-
Pyrroles
-
AAK1 protein, human
-
Protein Serine-Threonine Kinases
-
pyrrolo(2, 3-b)pyridine